1.
Tunisie Medicale [La]. 2010; 88 (10): 769-770
em Francês
| IMEMR
| ID: emr-130941
2.
Tunisie Medicale [La]. 2009; 87 (8): 554
em Francês
| IMEMR
| ID: emr-134417
3.
Tunisie Medicale [La]. 2009; 87 (2): 133-136
em Francês
| IMEMR
| ID: emr-92956
RESUMO
The Aim of this study is to review clinical data, histological and immunohistochemical findings and prognosis of stromal gastrointestinal tumors. A retrospective Study of 32 cases of stromal gastrointestinal tumors diagnosed in the Department of Pathology of Mongi Slim Hospital of Tunis from 1991 a 2004. The average age of the patients was of 54, 4 years, equal for sex. Tumors were essentially gastric [50%] and of the small intestine [37, 5%]. All the patients had surgical treatment. Gastro-intestinal Stromales Tumors or GIST represent the most frequent stromale tumor with 56, 2% of cases. After immunohistochimestry study, using CD117, this revision allows better management of GIST. Glivec +/- is the standard treatment of advanced GIST
Assuntos
Humanos , Masculino , Feminino , Tumores do Estroma Gastrointestinal/patologia , Imuno-Histoquímica , Proteínas Proto-Oncogênicas c-kit , Estudos Retrospectivos , Prognóstico
4.
Tunisie Medicale [La]. 2008; 86 (6): 628-629
em Inglês, Francês
| IMEMR
| ID: emr-90669